Blair T Lapointe

USPTO Granted Patents = 18 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 7)

Average Co-Inventor Count = 9.7

ph-index = 8

Forward Citations = 116(Granted Patents)

Location History:

Boston, MA (US) (2017 - 2019)
Brookline, MA (US) (2016 - 2020)
Sudbury, MA (US) (2021)

Company Filing History:

18 out of 2,405

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2016-2021

where 'Filed Patents' based on already Granted Patents

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11174248 - Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2021-11-16),

2. 11161854 - Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2021-11-02),

3. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2020-08-18),

4. 10689369 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof (2020-06-23),

5. 10584121 - Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof (2020-03-10),

6. 10377768 - Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-08-13),

7. 10344000 - Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof (2019-07-09),

8. 10287272 - Substituted indazole compounds as RORgammaT inhibitors and uses thereof (2019-05-14),

9. 10221146 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2019-03-05),

10. 10221142 - Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof (2019-03-05),

11. 10196354 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof (2019-02-05),

12. 9809561 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease (2017-11-07),

13. 9745265 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof (2017-08-29),

14. 9663522 - 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof (2017-05-30),

15. 9663502 - 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease (2017-05-30),

Hello! I am happy to present an article about the remarkable inventor Blair T Lapointe. Let's dive into the story of his passion for innovation and his significant contributions to the world of inventions.

**Title: Blair T Lapointe: Pioneering Innovation**

Introduction:

Blair T Lapointe, a distinguished inventor based in Brookline, MA (US), is known for his relentless pursuit of excellence and groundbreaking inventions that have left a profound impact on the industry. With a total of 18 patents to his name, Lapointe continues to inspire the next generation of inventors with his visionary approach and forward-thinking mindset.

Latest Patents:

Lapointe's recent patents include "Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors" and "Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors." These inventions focus on potent inhibitors of LRRK2 kinase, offering promising possibilities in the treatment and prevention of diseases such as Parkinson's Disease and other related disorders. The pharmaceutical compositions developed by Lapointe demonstrate his expertise in the field and dedication to advancing healthcare solutions.

Career Highlights:

Throughout his career, Lapointe has made significant contributions to renowned companies such as Merck Sharp & Dohme Corporation and Lycera Corporation. His innovative work has not only elevated these organizations but has also solidified his reputation as a forward-looking inventor with a knack for pushing boundaries and driving progress in the industry.

Collaborations:

In his pursuit of excellence, Lapointe has collaborated with esteemed professionals in the field. Some of his notable coworkers include Kenneth Jay Barr and Hongjun Zhang, who have worked alongside Lapointe to bring cutting-edge inventions to life. These collaborations have fostered a culture of innovation and shared success, leading to transformative outcomes in the realm of patents and inventions.

Conclusion:

Blair T Lapointe's passion for innovation and his unwavering commitment to excellence have positioned him as a true pioneer in the world of inventions. His latest patents stand as a testament to his ingenuity and dedication to creating a better future through groundbreaking discoveries. As Lapointe continues to inspire and empower the next generation of inventors, his legacy of innovation shines brightly, illuminating the path towards a more innovative and inventive world.

If you need more information or have any other requests, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.